O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 8.5 GBX -5.56% Market Closed
Market Cap: 37.7m GBX

Wall Street
Price Targets

OBI Price Targets Summary
Ondine Biomedical Inc

There are no price targets for OBI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ondine Biomedical Inc Competitors:
Price Targets
605186
Shanghai General Healthy Information and Technology Co Ltd
13% Upside
MYO
Myomo Inc
218% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
4% Upside
LUCD
Lucid Diagnostics Inc
175% Upside
688617
APT Medical Inc
23% Upside
BSX
Boston Scientific Corp
14% Upside
226400
Osteonic Co Ltd
47% Upside
LMAT
LeMaitre Vascular Inc
30% Upside

Revenue
Forecast

Revenue Estimate
Ondine Biomedical Inc

For the last 2 years the compound annual growth rate for Ondine Biomedical Inc's revenue is -32%. The projected CAGR for the next 4 years is 136%.

-32%
Past Growth
136%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ondine Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Ondine Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OBI's stock price target?
Not Available

OBI doesn't have any price targets made by Wall Street professionals.

What is Ondine Biomedical Inc's Revenue forecast?
Projected CAGR
136%

For the last 2 years the compound annual growth rate for Ondine Biomedical Inc's revenue is -32%. The projected CAGR for the next 4 years is 136%.

Back to Top